Stock A195940 HK INNO.N CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Company HK inno.N Corporation

Equities

A195940

KR7195940002

Pharmaceuticals

End-of-day quote Korea S.E.
Other stock markets
 18:00:00 2024-05-06 EDT 		5-day change 1st Jan Change
38,000 KRW -0.13% Intraday chart for HK inno.N Corporation -1.94% -14.51%
2022 Sebela Pharmaceuticals® Acquires Exclusive Licensing Rights from HK inno.N Corporation to Develop and Commercialize Tegoprazan in the U.S. and Canada CI
2022 Sebela Pharmaceuticals Enters an Exclusive Partnership with HK inno.N Corporation CI

Business Summary

HK Inno.N Corp is a Korea-based company mainly engaged in the manufacture and sale of prescription drugs. The Company operates its business through three segments. The Prescription Drug segment is engaged in the manufacture and sale of hormone drugs, anticancer drugs, high blood pressure drugs, gastroesophageal reflux disease drugs, blood nutrient supplies, the circulatory system and others. The Health Beauty and Beverage (HB&B) segment is engaged in the manufacture and sale of products such as hangover relieving products, as well as health drinks and food products. The Other segment is engaged in the trademark royalties business and other services. The Company sells its products within domestic market and to overseas markets.

Number of employees: 1,695

Sales per Business

KRW in Million2022Weight2023Weight Delta
Pharmaceutical
88.7 %
752,123 88.8 % 734,947 88.7 % -2.28%
H&B
11.3 %
94,399 11.2 % 93,961 11.3 % -0.46%

Sales per region

KRW in Million2022Weight2023Weight Delta
South Korea
96.0 %
791,556 93.5 % 795,847 96.0 % +0.54%
Others
3.1 %
24,898 2.9 % 25,321 3.1 % +1.70%
Japan
0.7 %
7,277 0.9 % 5,608 0.7 % -22.93%
China
0.2 %
9,991 1.2 % 1,247 0.2 % -87.52%
United States
0.1 %
12,800 1.5 % 885 0.1 % -93.08%

Managers

Managers TitleAgeSince
Seok-Hee Kang CEO
 Chief Executive Officer 68 -
Ha-Won Lee CMP
 Compliance Officer 45 -
Sang-Wook Park CTO
 Chief Tech/Sci/R&D Officer 53 -
Mu-Jeong Seo BRD
 Director/Board Member 55 -
Dal-Won Kwak BRD
 Director/Board Member 64 -
Myeong-Gi Choi SAM
 Sales & Marketing 57 -
Myung-Ho Eom HRO
 Human Resources Officer 53 -

Members of the board

Members of the board TitleAgeSince
Sang-Hyun Yoon BRD
 Director/Board Member 49 -
Jin-Ho Chai BRD
 Director/Board Member 53 -
Seok-Hee Kang CEO
 Chief Executive Officer 68 -
Dal-Won Kwak BRD
 Director/Board Member 64 -
Jae-Seok Park BRD
 Director/Board Member 48 -
Hu-Jeong Kim BRD
 Director/Board Member 50 -
Seong-Woo Ahn BRD
 Director/Board Member 53 -
Mu-Jeong Seo BRD
 Director/Board Member 55 -
Byeong-In Mun BRD
 Director/Board Member 54 -
Yeo-Won Son BRD
 Director/Board Member 65 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 28,329,891 14,644,869 ( 51.69 %) 0 51.69 %

Shareholders

NameEquities%Valuation
KOLMAR KOREA CO., LTD.
43.01 %
12,185,999 43.01 % 335 M ₩
National Pension Service of Korea
7.281 %
2,062,705 7.281 % 57 M ₩
HK inno.N Corp. ESOA
6.113 %
1,731,801 6.113 % 48 M ₩
Odin 10 LLC
4.077 %
1,154,950 4.077 % 32 M ₩
Medica Holdings LLC
2.392 %
677,616 2.392 % 19 M ₩
HK INNO.N CORPORATION
2.028 %
574,608 2.028 % 16 M ₩
Jackson National Asset Management LLC
0.0816 %
23,121 0.0816 % 636 310 ₩
Structured Invest SA
0.0150 %
4,260 0.0150 % 117 239 ₩
Dimensional Fund Advisors Ltd.
0.0147 %
4,161 0.0147 % 114 514 ₩
Korea Investment Management Co., Ltd.
0.009220 %
2,612 0.009220 % 71 885 ₩

Holdings

NameEquities%Valuation
HK INNO.N CORPORATION
2.03%
 574,608 2.03% 15,813,724 $
BLUEMTEC CO., LTD.
0.88%
 93,527 0.88% 989,980 $

Company contact information

HK inno.N Corp.

100 Pine Avenue Eulji-ro

04551, Seoul

+

http://www.inno-n.com
address HK inno.N Corporation(A195940)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Specialty & Advanced Pharmaceuticals

Sales per Business

Sales per region

Ratings for HK inno.N Corporation

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
38,000 KRW
Average target price
53,750 KRW
Spread / Average Target
+41.45%
Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Specialty & Advanced Pharmaceuticals

1st Jan change Capi.
HK INNO.N CORPORATION Stock HK inno.N Corporation
-14.51% 794M
MERCK KGAA Stock Merck KGaA
+6.52% 71.18B
KYOWA KIRIN CO. LTD. Stock Kyowa Kirin Co. Ltd.
+12.43% 9.23B
SK BIOPHARMACEUTICALS CO., LTD. Stock SK Biopharmaceuticals Co., Ltd.
-11.55% 5B
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD. Stock Shenyang Xingqi Pharmaceutical Co.,Ltd.
+48.05% 4.46B
YUHAN CORPORATION Stock Yuhan Corporation
+5.09% 3.95B
BETTA PHARMACEUTICALS CO., LTD. Stock Betta Pharmaceuticals Co., Ltd.
-14.74% 2.54B
INDIVIOR PLC Stock Indivior PLC
+20.00% 2.44B
CHANGCHUN BCHT BIOTECHNOLOGY CO. Stock Changchun BCHT Biotechnology Co.
-24.89% 2.36B
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. Stock Shanghai Shyndec Pharmaceutical Co., Ltd.
+21.45% 2.18B
Specialty & Advanced Pharmaceuticals
  1. Stock Market
  2. Equities
  3. A195940 Stock
  4. Company HK inno.N Corporation
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW